Ray Dalio's INCY Position Overview
Ray Dalio (via Bridgewater Associates, Lp) currently holds 328,590 shares of Incyte Corporation (INCY) worth $32.45 M, representing 0.12% of the portfolio. First purchased in 2021-Q2, this medium-term investment has been held for 19 quarters.
Based on 13F filings, Ray Dalio has maintained a strategic position in INCY, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2024, adding 363,145 shares. Largest reduction occurred in Q3 2025, reducing 262,800 shares.
Analysis based on 13F filings available since 2013 Q2
Ray Dalio's Incyte Corporation (INCY) Holding Value Over Time
Track share changes against reported price movement
Quarterly Incyte Corporation (INCY) Trades by Ray Dalio
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +197,306 | Add 150.29% | 328,590 | $98.77 |
| Q3 2025 | -262,800 | Reduce 66.69% | 131,284 | $84.81 |
| Q2 2025 | -233,647 | Reduce 37.22% | 394,084 | $68.10 |
| Q1 2025 | -44,046 | Reduce 6.56% | 627,731 | $60.55 |
| Q4 2024 | +363,145 | Add 117.66% | 671,777 | $69.07 |
| Q3 2024 | +181,504 | Add 142.77% | 308,632 | $66.10 |
| Q2 2024 | -239,484 | Reduce 65.32% | 127,128 | $60.62 |
| Q1 2024 | -1,422 | Reduce 0.39% | 366,612 | $56.97 |
| Q4 2023 | -2,165 | Reduce 0.58% | 368,034 | $62.79 |
| Q3 2023 | +52,454 | Add 16.51% | 370,199 | $57.77 |
| Q2 2023 | +41,234 | Add 14.91% | 317,745 | $62.25 |
| Q1 2023 | +5,070 | Add 1.87% | 276,511 | $72.27 |
| Q4 2022 | -72,810 | Reduce 21.15% | 271,441 | $80.32 |
| Q3 2022 | -46,692 | Reduce 11.94% | 344,251 | $66.64 |
| Q2 2022 | +340,133 | Add 669.42% | 390,943 | $75.97 |
| Q1 2022 | +28,716 | Add 129.97% | 50,810 | $79.41 |
| Q4 2021 | +16,047 | Add 265.37% | 22,094 | $73.41 |
| Q3 2021 | -22,201 | Reduce 78.59% | 6,047 | $68.79 |
| Q2 2021 | +28,248 | New Buy | 28,248 | $84.15 |
Ray Dalio's Incyte Corporation Investment FAQs
Ray Dalio first purchased Incyte Corporation (INCY) in Q2 2021, acquiring 28,248 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ray Dalio has held Incyte Corporation (INCY) for 19 quarters since Q2 2021.
Ray Dalio's largest addition to Incyte Corporation (INCY) was in Q4 2024, adding 671,777 shares worth $46.4 M.
According to the latest 13F filing for Q4 2025, Ray Dalio's firm, Bridgewater Associates, Lp, owns 328,590 shares of Incyte Corporation (INCY), valued at approximately $32.45 M.
As of the Q4 2025 filing, Incyte Corporation (INCY) represents approximately 0.12% of Ray Dalio's publicly disclosed stock portfolio, making it one of their key holdings.
Ray Dalio's peak holding in Incyte Corporation (INCY) was 671,777 shares, as reported at the end of Q4 2024.